Mumbai: Rakesh Jhunjunwala-backed Concord Biotech launched its IPO Friday, joining the ranks of the late billionaire’s other private investment portfolio companies such as Star Health, Metro Brands and Nazara Technologies that have gone public in the past couple of years. The ace investor often called India’s Warren Buffet, first invested in Concord in 2004 and … Read more
The Indian stock market is trading at an all-time high as strong inflows from foreign and domestic investors rush in on the back of improved earnings and macroeconomic indicators. However, retail investors are in two minds: whether to book profits or continue investing. For investors looking for signs of real economic recovery, not just the … Read more
Kotak Institutional Equities initiated coverage on Mankind Pharma stock with ‘Add’ rating for a price target of Rs 1,875. The domestic brokerage sees an 11% upside in the counter from current levels. “Mankind Pharma is well-positioned to further leverage its robust marketing prowess and reach. Within branded Rx, we expect a ramp-up of specialty and … Read more
Brokerage firm Goldman Sachs maintained a buy rating on Godrej Consumer, JPMorgan has an overweight rating on DLF, Axis Capital maintained a buy rating on Zydus Life, and Morgan Stanley retained its overweight stance on Biocon. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Goldman Sachs on … Read more
Indian markets opened on a subdued note on Thursday tracking muted global cues. The S&P BSE Sensex fell over 100 points while the Nifty50 held on to crucial support of 17,900 levels in the first 15 minutes of trade. Sectorally, buying was seen in realty, utilities, power, consumer discretionary, and consumer durables while selling was … Read more
The WHO emergency-use licence puts the ball back in the court of Bharat Biotech. (File) The World Health Organization’s (WHO) emergency-use licence to Bharat Biotech’s Covaxin recently ended months of suspense over the fate of the vaccine’s tumultuous journey that began since its development phase last year. India approved the vaccine for emergency use in … Read more
New Delhi: Drug firm Zydus Cadila on Monday said it has received final approval from the US health regulator to market Tofacitinib extended-release tablets, used to treat rheumatoid arthritis, in the American market. The company said it has received approval from the US Food and Drug Administration (USFDA) for the drug in 11 mg and … Read more
Health minister Mansukh Mandavia emphasised in the Rajya Sabha on Tuesday that political parties and state governments should not bring politics into the fight against the Covid-19 pandemic, which may have a third wave, even as he assured that the supply of vaccines, oxygen, medicines and other logistics is being ramped up. The Upper House … Read more
India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that the process is like a “marathon and not a 100-metre race”. Addressing a press briefing, Lav Agarwal, Joint Secretary, health ministry, said till date, … Read more
“Zydus has taken test licences for the development of both plants where Remdesivir is being manufactured,” Dr HG Koshia, commissioner, Food & Drug Control Authority, Gujarat, confirmed. Following the surge in cases of Covid-19, pharma major Cadila Healthcare (Zydus Cadila) is scaling up production capacity of Remdesivir injections, which are used to treat coronavirus patients. … Read more